Si Sun
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Oncology top 5%
Papers in
- Oncology 43
- Lung Cancer Research Studies 9
- Cancer Immunotherapy and Biomarkers 8
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 8
- Co-authors
- Qi Wu (25 shared papers)Shengrong Sun (22 shared papers)Juanjuan Li (8 shared papers)Yang Ouyang (2 shared papers)Jing Cai (27 shared papers)Xiaoyu Fu (2 shared papers)Xinyue Chen (1 shared paper)Zehua Wang (19 shared papers)
- Journals
- Frontiers in Oncology (7 papers)Frontiers in Immunology (6 papers)Oncotarget (5 papers)BMC Cancer (4 papers)Cell Death and Disease (4 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Si Sun
142 papers receiving 3.4k citations
Si Sun's Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 672
- Oncology 723
- Molecular Biology 1.4k
- Pulmonary and Respiratory Medicine 464
- Immunology 307
Countries citing papers authored by Si Sun
This map shows the geographic impact of Si Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si Sun more than expected).
Fields of papers citing papers by Si Sun
This network shows the impact of papers produced by Si Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si Sun. The network helps show where Si Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Si Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chalcone Derivatives: Role in Anticancer Therapy Hit paper breakdown → | 2021 | 304 |
| 2 | 2014 | 232 | |
| 3 | 2015 | 148 | |
| 4 | 2020 | 124 | |
| 5 | 2011 | 121 | |
| 6 | 2022 | 120 | |
| 7 | 2019 | 104 | |
| 8 | 2021 | 90 | |
| 9 | 2020 | 77 | |
| 10 | 2021 | 77 | |
| 11 | 2017 | 73 | |
| 12 | 2022 | 66 | |
| 13 | 2020 | 54 | |
| 14 | 2018 | 52 | |
| 15 | 2021 | 49 | |
| 16 | 2021 | 48 | |
| 17 | 2016 | 43 | |
| 18 | 2022 | 42 | |
| 19 | 2016 | 41 | |
| 20 | 2022 | 39 |
About Si Sun
Si Sun is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, having authored 152 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Epigenetics and DNA Methylation (13 papers), Lung Cancer Research Studies (9 papers), MicroRNA in disease regulation (9 papers), Extracellular vesicles in disease (8 papers), Cancer-related molecular mechanisms research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Endometrial and Cervical Cancer Treatments (7 papers). The work is most often cited by research in Cancer Research (672 citations), Oncology (723 citations), Molecular Biology (1.4k citations), Pulmonary and Respiratory Medicine (464 citations) and Immunology (307 citations). Si Sun has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Qi Wu, Shengrong Sun, Juanjuan Li, Yang Ouyang, Jing Cai, Xiaoyu Fu, Xinyue Chen, Zehua Wang, Juanjuan Li and Jian Zhang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, Oncotarget, BMC Cancer and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.